Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1465-542X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification ; volume:11 ; number:6 ; day:21 ; month:12 ; year:2009 ; pages:1-15 ; date:12.2009
Breast cancer research ; 11, Heft 6 (21.12.2009), 1-15, 12.2009

Creator: Powe, Desmond G.

Contributor: Akhtar, Gulfareen
Habashy, Hany Onsy
Abdel-Fatah, Tarek
Rakha, Emad A.
Green, Andrew R.
Ellis, Ian O.
SpringerLink (Online service)

DOI: 10.1186/bcr2461

URN: urn:nbn:de:1111-201603245975

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Powe, Desmond G.
Akhtar, Gulfareen
Habashy, Hany Onsy
Abdel-Fatah, Tarek
Rakha, Emad A.
Green, Andrew R.
Ellis, Ian O.
SpringerLink (Online service)

Other Objects (12)

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients

HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry

Is HER2 amplification predictable by digital immunohistochemistry?

Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers

RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification

HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma

HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis

Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues

Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers

Hochschulschrift

Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas

HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients

Amplification of HER2 is a marker for global genomic instability

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients

HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry

Is HER2 amplification predictable by digital immunohistochemistry?

Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers

RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification

HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma

HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis

Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues

Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers

Hochschulschrift

Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas

HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients

Amplification of HER2 is a marker for global genomic instability

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients

HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry

Is HER2 amplification predictable by digital immunohistochemistry?

Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers

RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification

HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma

HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis

Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues

Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers

Hochschulschrift

Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas

HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients

Amplification of HER2 is a marker for global genomic instability

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients

HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry

Is HER2 amplification predictable by digital immunohistochemistry?

Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers

RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification

HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma

HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis

Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues

Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers

Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas

HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients

Amplification of HER2 is a marker for global genomic instability

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients

HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry

Is HER2 amplification predictable by digital immunohistochemistry?

Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers

RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification

HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma

HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis

Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues

Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers

Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas

HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients

Amplification of HER2 is a marker for global genomic instability

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients

HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry

Is HER2 amplification predictable by digital immunohistochemistry?

Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers

RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification

HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma

HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis

Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues

Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers

Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas

HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients

Amplification of HER2 is a marker for global genomic instability

Related objects

Reset password